Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × camrelizumab × Clear all

Phase

Status

Unknown 3 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 8 Nasopharyngeal Carcinoma 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Colorectal Neoplasms 4 Pancreatic Neoplasms 3 Liver Neoplasms 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Unresectable Gallbladder Cancer 1 Sarcoma 1 Salivary Gland Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Non Squamous Non Small Cell Lung Cancer 1 Nasopharyngeal Neoplasms 1 Multiple Primary Lung Cancer 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic Solid Tumors 1 Locally Advanced Rectal Cancer 1 Liver Diseases 1 Leukemia, Myeloid, Acute 1 Her-2 Negative Breast Cancer 1

Interventions

Doxorubicin 14 pembrolizumab 9 Gemcitabine 8 Surgical Procedures, Operative 7 Nivolumab 6 Blood Specimen Collection 6 Trabectedin 5 Surveys and Questionnaires 5 Ifosfamide 5 Drug Therapy 5 Cyclophosphamide 5 Radiotherapy 4 Radiation Dose Hypofractionation 4 liposomal doxorubicin 3 fludarabine 3 atezolizumab 3 anlotinib 3 Radiation 3 Observation 3 Ipilimumab 3 Docetaxel 3 Biopsy 3 trastuzumab deruxtecan 2 selinexor 2 repotrectinib 2 pazopanib 2 fluzoparib 2 fludarabine phosphate 2 eribulin 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06074692 2023-10-31

PRIMA

Ruijin Hospital

Phase 2 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡